Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Blood Test Identifies Immune Response in Multiple Sclerosis Patients, Paves Way for New Treatments techtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techtimes.com Daily Mail and Mail on Sunday newspapers.
The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical.
BioMedNewsBreaks — Clene Inc (NASDAQ: CLNN) Announces Participation Schedule for Upcoming May Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.